In an effort to provide Nigerians with fast and credible solutions to relieve the burden of frequently suffered pains, GlaxoSmithKline Nigeria Plc (GSK) has unveiled Cafenol Extra to the Nigerian market. This further authenticates the global company's commitment to enabling people achieve their full potentials.

GSK Cafenol Extra contains three internationally proven active ingredients of Paracetamol-200mg, AcetylSalicylic-400mg acid and caffeine - 30mg. The solution is reputed with fast, extra effective triple action relief against headache, backache and rheumatic pains.

Speaking at the grand launch of the product held recently at Royal Tropicana Hotel, Kano, the managing director of GSK, Mr. Sameer Goel, stated that Cafenol Extra is a product of a careful research and innovation aligned to GSK's global quest: "to improve the quality of human life by helping people do more, feel better and live longer."

"With Cafenol Extra, we have brought the trusted heritage of Cafenol of over 30 years to bear in the formulation of Cafenol Extra. Cafenol Extra has been specially formulated to contain triple active ingredients -Paracetamol 200mg, Acetylsalicylic acid 400mg and Caffeine-30mg. These triple active ingredients work together to produce powerful triple action effect against headache, backache and rheumatic pain," he explained.

Mr. Goel reiterated GSK's belief in Nigeria and will continue to invest in it to add value to the lives of its populace. He commended the Northern market for its overwhelming patronage of Cafenol. "It is to pay tribute to Kano in particular and the entire northern states of Nigeria in general for their acceptance and usage of Cafenol over the years. That trusted Cafenol which has been an integral part of the way of life for most northerners - helping to make pain go fast -  has today given birth to a new variant (if you like , a new baby) known as Cafenol Extra," he enthused.